School of Public Health
University of Memphis Photo
James Gurney

James Gurney

James G. Gurney, Ph.D.
Associate Dean
School of Public Health
Professor and Director, Division of Epidemiology, Biostatistics,
and Environmental Health Sciences
Contact information:
Phone: 901-678-1673
Robison Hall 228
Curriculum Vitae


  • Ph.D., Epidemiology, School of Public Health, University of Washington, Seattle
  • M.S., Epidemiology, School of Public Health, University of Washington, Seattle
  • M.S.W., School of Social Work, University of Washington, Seattle
  • B.A., Liberal Studies, Antioch University, Seattle
  • A.A.S., Chemical Technology, Seattle Central Community College, Seattle

Research Interests

  • Cancer epidemiology and survivorship, including long-term treatment-related outcomes in children and adults
  • Health, psychosocial, and functional outcomes related to chronic diseases and conditions in children and adolescents, including sickle cell disease, complex congenital heart disease, obesity and metabolic disorders, autism, trauma
  • Causal inference, bias, and methodological issues in the design, analysis, and interpretation of clinical and epidemiologic research studies

Teaching Interests

  • Epidemiologic Methods: Causation and Bias
  • Clinical Epidemiology

James G. Gurney, Ph.D. –Hardin Endowed Professor, Associate Dean, and Director of the Division of Epidemiology, Biostatistics and Environmental Health in the School of Public Health. Dr. Gurney is an epidemiologist with extensive experience conducting multidisciplinary research on health outcomes among children with chronic conditions. In particular, he is an expert on long-term adverse medical and psychosocial effects of cancer treatment among childhood cancer survivors. Dr. Gurney is an adjunct faculty member at St. Jude Children’s Research Hospital where he collaborates on studies of cancer survivorship and health effects of sickle cell disease. He also has research experience in autism, complex congenital heart disease, and pediatric and adolescent diabetes and insulin resistance related to obesity. Dr. Gurney’s research has been funded by a variety of sources, including the National Institutes of Health, the American Cancer Society, Hope Street Kids, the Children’s Cancer Research Fund, several state health departments, and most recently, the FedEx Institute of Technology at the University of Memphis. Dr. Gurney is a core member of the Data Safety Monitoring Board for the National Institute of Neurological Diseases and Stroke, is on the Scientific Advisory Board of the Central Brain Tumor Registry of the United States, and is a frequent member of scientific peer review panels for the National Institutes of Health. He also is an Associate Editor and Editorial Board Member for the Annals of Epidemiology, and an elected Board Member and Fellow of the American College of Epidemiology.

Selected Publications (2013-2014)

  • Ojha RP, Tota JE, Offutt-Powell TN, Klosky JL, Ashokkumar R, Gurney JG.The accuracy of human papillomavirus vaccination status based on adult proxy recall or household immunization records for adolescent females in the United States: Results from the National Immunization Survey-Teen. Annals Epidemiol 2013;23:281-285.
  • Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, Green DM, Armstrong GT, Nottage KA, Jones KE, Sklar CA, Srivastava DK, Robison LL. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 2013;309:2371-2381.
  • Nottage K, Gurney JG, Smeltzer M, Castellanos M, Hudson MM, Hankins JS. Trends in transfusion burden among long-term survivors of childhood hematological malignancies. Leuk Lymphoma 2013;54:1719-1723.
  • Ness KK, Jones KE, Smith WA, Spunt SL, Wilson CL, Armstrong GA, Srivastava DK, Robison LL, Hudson MM, Gurney JG.  Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial tumors of childhood:  Results from the St. Jude Lifetime Cohort Study. Arch Phys Med Rehab 2013;94:1451-1457.
  • Ojha RP, Tota JE, Offutt-Powell TN, Klosky JL, Minniear TD, Jackson BE, Gurney JG. Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers. PLoS One 2013 Aug 5;8(8):e70349. doi: 10.1371/journal.pone.0070349.
  • Nottage, KA, Hankins JS, Smeltzer M, Mzayek F, Wang WC, Aygun B, Gurney JG. Hydroxyurea use and hospitalization trends in a comprehensive pediatric sickle cell program. PLoS One 2013 Aug 14;8(8):e72077. doi: 10.1371/journal.pone.0072077.
  • Ojha RP, Gurney JG, Green DM. Clinical prediction models for anthracycline-associated cardiotoxicity among pediatric cancer survivors – Ready for prime time? Pediatr Blood Cancer 2013;60:1245-1246. [Invited editorial].
  • Huang IC, Brinkman TM, Kenzik K, Gurney JG, Ness KK, Lanctot J, Shenkman E, Robison LL, Hudson MM, Krull KR. Association between the prevalence of symptoms and health-related quality of life in adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study. J Clin Oncol 2013:31:4242-4251.
  • Krull KR, Brinkman TM, Li C, Armstrong GT, Ness KK, Srivastava DK, Gurney JG, Kimberg C, Krasin MJ, Pui CH, Robison LL, Hudson MM. Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort Study. J Clin Oncol 2013;31:4407-4415.
  • Ojha RP, Gurney JG. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and mortality in pediatric acute lymphoblastic leukemia: A systematic review. Leuk Lymphoma 2014;55:67-73.
  • Landier W, Knight K, Wong FL, Lee J, Thomas O, Kim H, Kreissman SG, Schmidt ML, Chen L, London WB, Gurney JG, Bhatia S. Ototoxicity in children with high-risk neuroblastoma – prevalence, risk factors, and concordance of grading scales: A report from the Children’s Oncology Group. J Clin Oncol 2014;32:527-534.
  • Bass JK, Huang J, Onar-Thomas A, Chang KW, Bhagat SP, Chintagumpala M, Bartels U, Gururangan S, Hassall T, Heath JA, McCowage G, Cohn RJ, Fisher MJ, Robinson G, Broniscer A, Gajjar A, Gurney JG. Concordance between the Chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in medulloblastoma patients treated with cisplatin. Pediatr Blood Cancer 2014;61:601-605.
  • Fox E, Mosse YP, Meany HM, Gurney JG, Khanna G, Jackson HA, Gordon G, Shusterman S, Park JR, Cohn SL, Adamson PC, McGrady P, London WB, Maris JM, Balis FM. Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: A report from the Children’s Oncology Group (ANBL0621). Pediatr Blood Cancer 2014;61:990-996.
  • Ojha RP, Offutt-Powell TN, Gurney JG. Influenza vaccination coverage among adult survivors of pediatric cancer. Am J Prev Med 2014;46:552-558.
  • Oancea SC, Brinkman TM, Ness KK, Krull KR, Smith WA, Srivastava DK, Robison LL, Hudson MM, Gurney JG. Emotional distress among adult childhood cancer survivors. J Cancer Surviv 2014;8:293-303.
  • Gurney JG, Bass JK, Onar-Thomas A, Huang J, Chintagumpala M, Bouffet E, Hassall T, Gururangan S, Health JA, Kellie S, Cohn R, Fisher MJ, Pai Panandiker A, Merchant TE, Srinivasan A, Wemore C, Qaddoumi I, Stewart CF, Armstrong GT, Broniscer A, Gajjar A. Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average risk or high risk medulloblastoma. Neuro-Oncol 2014;16:848-855.
  • Gurney JG, Kaste SC, Liu W, Srivastava DK, Chemaitilly W, Ness KK, Lanctot JQ, Ojha RP, Nottage KA, Wilson CL, Li Z, Robison LL, Hudson MM. Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: Results from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 2014;61:1270-1276.
  • Schreiber JE, Gurney JG, Palmer SL, Bass JK, Wang M, Chen S, Zhang H, Swain M, Chapieski ML, Bonner MJ, Mabbott DJ, Knight S, Armstrong CL, Boyle R, Gajjar A. Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma. Neuro Oncol 2014 16:1129-36.
  • Nolan VG, Krull KR, Gurney JG, Leisenring W, Robison LL, Ness KK. Predictors of future health-related quality of life in survivors of adolescent cancer. Pediatr Blood Cancer 2014;61:1891-1894.
  • Ojha RP, Jackson BE, Tota JE, Offut-Powell TN, Hudson MM, Gurney JG. Younger age distribution of cervical cancer incidence among survivors of pediatric and young adult cancers. Gynecol Oncol 2014;134:309-313.
  • Oancea SC, Gurney JG, Ness KK, Ojha RP, Tyc VL, Klosky JL, Srivastava DK, Stokes DC, Robison LL, Hudson MM, Green DM. Cigarette smoking and pulmonary function in adult survivors of childhood cancer exposed to pulmonary-toxic therapy: Results from the St. Jude Lifetime Cohort Study. Cancer Epidemol Biomarkers Prev 2014;23:1938-1943.
  • Hudson MM, Oeffinger KC, Jones K, Brinkman TM, Krull KR, Mulrooney DA, Mertens A, Castellino SM, Casillas J, Gurney JG, Nathan PC, Leisenring W, Robison LL, Ness KK. Age-dependent changes in health status in the Childhood Cancer Survivor Cohort. J Clin Oncol, in press.
  • Wilson CL, LiuL, Yang JJ, Kang G, Ojha RP, Neale G, Srivastava DK, Gurney JG, Hudson MM, Robison LL, Ness KK. Genetic and clinical factors associated with obesity among adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort. Cancer, in press.


SPH 2014 Magazine
True Blue Goes Green 2013 Video
New SPH Video
What Students Are Saying

Master of Health Administration
Master of Public Health
SBS PhD Program
Epi PhD Program
HSP PhD Program
Healthcare Interpreter Program
Back to SPH Homepage

Text Only | Print | Got a Question? Ask TOM | Contact Us | Memphis, TN 38152 | 901/678-2000 | Copyright 2015 University of Memphis | Important Notice | Last Updated: 
Last Updated: 1/8/15